According to the study conducted by Merikangas et al., (2012), titled “Epidemiology of Substance Use Disorders,” the prevalence rates of both alcohol and drug dependence (1.3% and 1.8% respectively) are about one-fourth the magnitude of abuse (5.2% and 7.1%, respectively). Taken together, the lifetime prevalence rates of substance use disorders was 6.5% for alcohol and 8.9% for illicit drugs. As per the study by Carney et al. (2020), alcohol abuse was the most common lifetime Substance use disorder diagnosis (9.3%), followed by alcohol dependence (7.3%) and drug abuse.
DelveInsight's "Substance use disorder Market Insights, Epidemiology, and Market Forecast 2030" reports deliver an in-depth understanding of the Substance use disorder Market, historical and forecasted epidemiology, the pipeline insight as well as the Substance use disorder market size and shares analysis in the seven major markets (7MM) (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Substance use disorder Market Growth Analysis
The Substance use disorder market analysis section of the report helps to build a detailed comprehension of the historic, current, and forecasted Substance use disorder market trends and growth by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers and demand for better technology.
The report gives a thorough detail of Substance use disorder market size and shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Substance use disorder Epidemiology Forecast
Epidemiological studies of substance use and substance use disorders (SUDs) have provided an abundance of data on the patterns of substance use in nationally representative samples across the world. The striking increase in substance use disorder prevalence rates from ages 13 to 18 highlights adolescence as the key period of development of substance use disorders.
The Substance use disorder epidemiology section covers insights about historical and current Substance use disorder patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Substance use disorder Pipeline Analysis
The Substance use disorder Pipeline and Drugs Uptake section focus on the rate of uptake of the potential drugs recently launched in the Substance use disorder market or expected to get launched in the market during the study period. The analysis covers the Substance use disorder market uptake by drugs; patient uptake by therapies; and sales of each drug.
Some of the key companies in the Substance Use Disorder market include:
MediciNova
Omeros Corp.
KemPharm
InterveXion Therapeutics
Pear Therapeutics
And others.
Substance Use Disorder Therapies Covered in the report includes Ibudilast (MN-166), OMS405, KP879, IXT-m200, reSET, and many others.
Source: Substance Use Disorder Market Growth